Cart
sales@molnova.com
Deoxyandrographolide
CAS No. 79233-15-1
Deoxyandrographolide( 14-deoxyandrographolide )
Catalog No. M29612 CAS No. 79233-15-1
Deoxyandrographolide potentiates NGF-induced neurite outgrowth. Deoxyandrographolide suppresses the production of proinflammatory mediators TNF-α and IL-6.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 166 | In Stock |
|
| 2MG | 100 | In Stock |
|
| 5MG | 158 | In Stock |
|
| 10MG | 235 | In Stock |
|
| 25MG | 375 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDeoxyandrographolide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDeoxyandrographolide potentiates NGF-induced neurite outgrowth. Deoxyandrographolide suppresses the production of proinflammatory mediators TNF-α and IL-6.
-
DescriptionDeoxyandrographolide potentiates NGF-induced neurite outgrowth. Deoxyandrographolide suppresses the production of proinflammatory mediators TNF-α and IL-6.(In Vitro):Deoxyandrographolide showed inhibitory activity on LPS-induced NO production in RAW 264.7 macrophage cells.(In Vivo):In L6 myotubes, Deoxyandrographolide dose-dependently stimulated glucose uptake by enhancing the translocation of glucose transporter 4 (GLUT4) to cell surface, without affecting the total cellular GLUT4 and GLUT1 content. These effects of Deoxyandrographolide were additive to insulin.
-
In Vitro——
-
In Vivo——
-
Synonyms14-deoxyandrographolide
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorIL Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number79233-15-1
-
Formula Weight334.456
-
Molecular FormulaC20H30O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (299.00 mM)
-
SMILESCC1=C(CCC2=CCOC2=O)[C@]2(C)CC[C@@H](O)[C@@](C)(CO)[C@H]2CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
IL-15-IN-1
IL-15-IN-1 is a selective?and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).
-
Secukinumab B
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
-
Brodalumab
Brodalumab (AMG 827) is a human monoclonal IgG2 antibody targeting the interleukin 17 receptor (IL-17R), commonly used as an immunosuppressant in treating psoriasis.
